Phase I study of H3B-6545 in patients (pts) with estrogen receptor-positive (ER plus ) breast cancer

被引：0
|
作者：
Ono, M. [1 ]
Kogawa, T. [1 ]
Kitano, S. [1 ]
Shimoi, T. [2 ]
Yamamoto, K. [2 ]
Kobayashi, S. [3 ]
Ichikawa, Y. [3 ]
Yamaguchi, K. [4 ]
Otake, Y. [3 ]
Hojo, S. [5 ]
Yonemori, K. [2 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Adv Med Dev Ctr, Tokyo, Japan
[2] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[3] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Japan & Asia Clin Dev,Dept Oncol, Tokyo, Japan
[4] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Clin Pharmacol Sci Dept, Tokyo, Japan
[5] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Clin Data Sci Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55O
引用
收藏
页码：S1487 / S1487
页数：1
相关论文
共 50 条
  • [41] Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer
    Wang, Yiyu
    Sun, Meng
    He, Zhong
    Han, Ying
    Song, Yinhong
    Liang, Jianjia
    Wang, Huimin
    Qin, Ye
    Deng, Zhangshuang
    HELIYON, 2024, 10 (12)
  • [42] MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer
    Frick, Elisabet Alexandra
    Kristjansdottir, Karen
    Ragnarsdottir, Snaedis
    Vilhjalmsson, Arnar Ingi
    Bustos, Maria Rose
    Vidarsdottir, Linda
    Gudjonsson, Thorkell
    Sigurdsson, Stefan
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2024, 18
  • [43] Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC).
    Traina, T. A.
    Rugo, H.
    Caravelli, J.
    Yeh, B.
    Panageas, K.
    Bruckner, J.
    Norton, L.
    Park, J.
    Hudis, C.
    Dickler, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 133S - 133S
  • [44] Enhanced efficacy of ARV-471, a novel PROTAC® estrogen receptor degrader, in combination with targeted agents in estrogen receptor-positive (ER plus ) breast cancer models
    Teh, Jessica
    Bortolon, Elizabeth
    Pizzano, Jennifer
    Pannone, Melissa
    Landrette, Sean
    Gedrich, Richard
    Taylor, Ian
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
  • [46] Factors Associated With Node-positive Disease in Estrogen Receptor-Positive Breast Cancer Patients
    Gallagher, Julia
    Elleson, Kelly M.
    Englander, Katherine
    Chintapally, Neha
    Sun, Weihong
    Whiting, Junmin
    Laronga, Christine
    Lee, Marie Catherine
    JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 327 - 331
  • [47] Resistance to Endocrine Therapy in Estrogen Receptor-Positive (ER plus ) Breast Cancer Is Dependent upon Phosphatidylinositol-3 Kinase (PI3K) Signaling
    Miller, T. W.
    Fox, E. M.
    Gonzalez-Angulo, A. M.
    Hennessy, B. T.
    Mills, G. B.
    McKinley, E. T.
    Manning, H. C.
    Arteaga, C. L.
    CANCER RESEARCH, 2009, 69 (24) : 516S - 516S
  • [48] Late disease recurrence in estrogen receptor positive (ER plus ) premenopausal breast cancer (BC)
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Rea, Silvio
    Hoo, William Soo
    Cantor, Tom
    CANCER RESEARCH, 2014, 74 (19)
  • [49] evERA Breast Cancer (BC): Phase III study of giredestrant plus everolimus vs exemestane plus everolimus in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced or metastatic BC (ER+, HER2-LA/mBC)
    Mayer, Erica L.
    Tolaney, Sara M.
    Brufsky, Adam
    Gradishar, William John
    Jhaveri, Komal L.
    Martin, Miguel
    Moscetti, Luca
    Schneeweiss, Andreas
    Vidal, Gregory A.
    Cortazar, Patricia
    Feldman, Merilin
    Day, Bann-mo
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
    Gao, Pin
    Wang, Xiang
    Jin, Ying
    Hu, Wenquan
    Duan, Yajun
    Shi, Aiping
    Du, Ye
    Song, Dong
    Yang, Ming
    Li, Sijie
    Han, Bing
    Zhao, Gang
    Zhang, Hongquan
    Fan, Zhimin
    Miao, Qing Robert
    BREAST CANCER RESEARCH, 2018, 20
12345